Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPM1B | O75688 | 1/20 | 0.56 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.56 |
| ▸ | PPP1CC | P36873 | 1/20 | 0.56 |
| ▸ | POLB | P06746 | 2/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.43 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.33 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.33 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.33 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.33 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.33 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4036804 | 1.00 | PPM1B (0.56) | PPM1BPTPN1PPP1CCPOLBCYP2C19 | |
| SCHEMBL257600 | 1.00 | PPM1B (0.56) | PPM1BPTPN1PPP1CCPOLBCYP2C19 | |
| SCHEMBL5490936 | 1.00 | PPM1B (0.56) | PPM1BPTPN1PPP1CCPOLBCYP2C19 | |
| SCHEMBL20075282 | 0.87 | CYP2C19 (0.50) | PPM1BPTPN1PPP1CCPOLBCYP2C19 | |
| SCHEMBL2081942 | 0.87 | CYP2C19 (0.50) | PPM1BPTPN1PPP1CCPOLBCYP2C19 | |
| SCHEMBL13139972 | 0.87 | CYP2C19 (0.50) | PPM1BPTPN1PPP1CCPOLBCYP2C19 | |
| SCHEMBL2080386 | 0.87 | CYP2C19 (0.50) | PPM1BPTPN1PPP1CCPOLBCYP2C19 | |
| SCHEMBL8919476 | 0.87 | CYP2C19 (0.50) | PPM1BPTPN1PPP1CCPOLBCYP2C19 | |
| SCHEMBL15319047 | 0.81 | PPM1B (0.50) | PPM1BPTPN1PPP1CCPOLBCYP2C19 | |
| SCHEMBL392329 | 0.79 | PPM1B (0.59) | PPM1BPTPN1PPP1CCPOLBCYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250127801-A1 | BRIDGED TRICYCLIC CARBAMOYLPYRIDONE COMPOUNDS AND USES THEREOF | GILEAD SCIENCES, INC. | 2025-04-24 | — | — | US | disclosed |
| US-5623078-A | Process for producing an intermediate of a new quinolone compound | CHISSO CORPORATION (JP) | 1997-04-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250127801-A1 | BRIDGED TRICYCLIC CARBAMOYLPYRIDONE COMPOUNDS AND USES THEREOF | SDHA, SDHB, DPYD | PPM1B 1571/4885PTPN1 3232/4885PPP1CC 3237/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.